tbuckley/cabot-search huggingface dataset:
Endoscopic ultrasound-guided stent-in-stent placement for management of migrated hepaticogastrostomy stent
Authors: Marcin Polkowski, Michal F. Kaminski, Karolina Jasionek, Jaroslaw Regula
Journal: Endoscopy (2021)

Stent misdeployment or migration into the peritoneal cavity is a dreaded complication of endoscopic ultrasound (EUS)-guided hepaticogastrostomy. It occurs in around 2.5 % procedures, is potentially fatal, and usually treated surgically [1]. A few cases have been reported in which this complication was managed by repositioning the stent using transluminal endoscopic surgery techniques [2] [3] or by EUS-guided stent-in-stent insertion [4] [5]. Here we present a case of EUS-guided puncture of the migrated stent through the wall of the gastroesophageal junction followed by stent-in-stent insertion.
Is cancer biology different in older patients?
Authors: Yannick Van Herck, Annelies Feyaerts, Shabbir Alibhai, Demetris Papamichael, Lore Decoster, Yentl Lambrechts, Michael Pinchuk, Oliver Bechter, Jaime Herrera-Caceres, Frédéric Bibeau, Christine Desmedt, Sigrid Hatse, Hans Wildiers
Journal: The Lancet Healthy Longevity (2021)

Roughly 50% of cancer cases occur in people aged 65 years or older. Older people are often diagnosed at a later stage and might receive less (intensive) treatment, which might affect the outcome. In addition, an older age might be associated with biological differences in tumour and microenvironment behaviour, a domain that has been poorly studied so far. In this narrative Review of published literature, we explored the reported differences in tumour biology according to age in five major cancer types: breast, colorectal, prostate, lung, and melanoma. Our literature search uncovered clear differences in tumour histology and subtype distribution in older people compared with younger patients, as well as age-specific patterns of tumour mutations and other molecular alterations. Several studies also indicate notable changes in tumour-infiltrating immune cells in tumours of older versus younger people, although this research is still in its infancy. More research is needed and might lead to a better understanding of the biology of ageing in relation to malignancy. This knowledge could provide new perspectives for more personalised cancer treatments, eventually improving the global outcomes of older patients with cancer.
Anticoagulant Therapy in Patients Hospitalized With COVID-19
Authors: Lana Wahid, Thomas L. Ortel
Journal: JAMA Internal Medicine (2021)

Alex C. Spyropoulos, MD; Mark Goldin, MD; Dimitrios Giannis, MD, MSc; Wassim Diab, MD; Janice Wang, MD; Sameer Khanijo, MD; Andrea Mignatti, MD; Eugenia Gianos, MD; Marc Cohen, MD; Gulru Sharifova, MD; Jeet M. Lund, DO; Alfonso Tafur, MD, MSc, RPVI; Paul A. Lewis, MD, CPE; Kevin P. Cohoon, DO; Husneara Rahman, PhD; Cristina P. Sison, PhD; Martin L. Lesser, PhD; Kanta Ochani, MBBS; Nirav Agrawal, MBBS; Judith Hsia, MD; Victoria E. Anderson, MPH; Marc Bonaca, MD, MPH; Jonathan L. Halperin, MD; Jeffrey I. Weitz, MD; HEP-COVID Investigators; Lori Ohanesian; Michelle Glater; Christopher Ho; Annamaria Iakovou; Daniel Ying; Manile Dastagir; Alex Convissar; Seerat Aujla; Elizabeth Mathew; Vani Thiyagarajan; Tricia Lewis; Luis Gruberg; Paul Maccaro; Dana Kuziw; Bhumi Pandhi; George Surguladze; Ashley M. Eapen; Alexandra Pantea; Phyllis Suen; John Flynt; Michael Krzyzak; Kamal Sharma; Amanda Steadham; Sherry L. McLean; Karen Herring; Karen Maroney; Kambiz Zorriasateyn; Bernardo Vargas; Marisa Durante; Ujala Bhokary; Linda Pierchala; Elizabeth A. Fisher; Debi L. Oxenberg; Alison Sabados; Omair A. Chaudhary; Shelley Schultz; Sue Cotey; Connie Hess; Hope Cruse; Daniel Uy; Sunita Sharma; Kevin Molina; Daliya Jagat; Bandyopadhyay Dehali
527P Phase I study of the novel prodrug MIV-818 in patients with hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (iCCA) or liver metastases (LM)
Authors: D. Sarker, T.R.J. Evans, E. Van Cutsem, H. Prenen, M.R. Middleton, S. Bhoi, K. Tunblad, F. Oberg, T. Morris, R. Plummer
Journal: Annals of Oncology (2021)
CD8<sup>+</sup> TILs in NSCLC differentiate into TEMRA via a bifurcated trajectory: deciphering immunogenicity of tumor antigens
Authors: Sung-Woo Lee, He Yun Choi, Gil-Woo Lee, Therasa Kim, Hyun-Ju Cho, In-Jae Oh, Sang Yun Song, Deok Hwan Yang, Jae-Ho Cho
Journal: Journal for ImmunoTherapy of Cancer (2021)

Background CD8 + tumor-infiltrating lymphocytes (TILs) comprise phenotypically and functionally heterogeneous subpopulations. Of these, effector memory CD45RA re-expressing CD8 + T cells (Temra) have been discovered and characterized as the most terminally differentiated subset. However, their exact ontogeny and physiological importance in association with tumor progression remain poorly understood. Methods We analyzed primary tumors and peripheral blood samples from 26 patients with non-small cell lung cancer and analyzed their phenotypes and functional characteristics using flow cytometry, RNA-sequencing, and bioinformatics. Results We found that tumor-infiltrating Temra (tilTemra) cells largely differ from peripheral blood Temra (pTemra), with distinct transcriptomes and functional properties. Notably, although majority of the pTemra was CD27 − CD28 − double-negative (DN), a large fraction of tilTemra population was CD27 + CD28 + double-positive (DP), a characteristic of early-stage, less differentiated effector cells. Trajectory analysis revealed that CD8 + TILs undergo a divergent sequence of events for differentiation into either DP or DN tilTemra. Such a differentiation toward DP tilTemra relied on persistent expression of CD27 and CD28 and was associated with weak T cell receptor engagement. Thus, a higher proportion of DP Temra was correlated with lower immunogenicity of tumor antigens and consequently lower accumulation of CD8 + TILs. Conclusions These data suggest a complex interplay between CD8 + T cells and tumors and define DP Temra as a unique subset of tumor-specific CD8 + TILs that are produced in patients with relatively low immunogenic cancer types, predicting immunogenicity of tumor antigens and CD8 + TIL counts, a reliable biomarker for successful cancer immunotherapy.
Association between first language and SARS-CoV-2 infection rates, hospitalization, intensive care admissions and death in Finland: a population-based observational cohort study
Authors: Ville Holmberg, Heli Salmi, Salla Kattainen, Jukka Ollgren, Anu Kantele, Juulia Pynnönen, Asko Järvinen, Erik Forsblom, Suvi Silén, Sanna-Maria Kivivuori, Atte Meretoja, Johanna Hästbacka
Journal: Clinical Microbiology and Infection (2021)

Motivated by reports of increased risk of coronavirus disease 2019 (COVID-19) in ethnic minorities of high-income countries, we explored whether patients with a foreign first language are at an increased risk of COVID-19 infections, more serious presentations, or worse outcomes.In a retrospective observational population-based quality registry study covering a population of 1.7 million, we studied the incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), admissions to specialist healthcare and the intensive care unit (ICU), and all-cause case fatality in different language groups between 27th February and 3rd August 2020 in Southern Finland. A first language other than Finnish, Swedish or Sámi served as a surrogate marker for a foreign ethnic background.In total, 124 240 individuals were tested, and among the 118 300 (95%) whose first language could be determined, 4005 (3.4%) were COVID-19-positive, 623 (0.5%) were admitted to specialized hospitals, and 147 (0.1%) were admitted to the ICU; 254 (0.2%) died. Those with a foreign first language had lower testing rates (348, 95%CI 340-355 versus 758, 95%CI 753-762 per 10 000, p < 0.0001), higher incidence (36, 95%CI 33-38 versus 22, 95%CI 21-23 per 10 000, p < 0.0001), and higher positivity rates (103, 95%CI 96-109 versus 29, 95%CI 28-30 per 1000, p < 0.0001). There was no significant difference in ICU admissions, disease severity at ICU admission, or ICU outcomes. Case fatality by 90 days was 7.7% in domestic cases and 1.2% in those with a foreign first language, explained by demographics (age- and sex-adjusted HR 0.49, 95%CI 0.21-1.15).The population with a foreign first language was at an increased risk for testing positive for SARS-CoV-2, but when hospitalized they had outcomes similar to those in the native, domestic language population. This suggests that special attention should be paid to the prevention and control of infectious diseases among language minorities.
1312P Prognostic impact of KRAS status in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitor monotherapy
Authors: G. Pelizzari, C. Corvaja, G. Targato, S. Buriolla, M. Bortolot, S. Torresan, A. Fantin, G. De Maglio, C. Rossetto, S. Rizzato, G. Fasola, A. Follador
Journal: Annals of Oncology (2021)
Diverse kinase alterations and myeloid-associated mutations in adult histiocytosis
Authors: Jia Chen, Ai-lin Zhao, Ming-hui Duan, Hao Cai, Xue-min Gao, Ting Liu, Jian Sun, Zhi-yong Liang, Dao-bin Zhou, Xin-xin Cao, Jian Li
Journal: Leukemia (2021)
152P Meta-analysis of the prognostic value of circulating tumor DNA (ctDNA) in patients (pts) with early breast cancer (EBC)
Authors: N. Saoudi Gonzalez, A. Papakonstantinou, I. Pimentel, A. Suñol, M. Bellet, E. Zamora, C. Ortiz, C. Saura Manich, G. Villacampa Javierre, A.M. Antunes De Melo e Oliveira
Journal: Annals of Oncology (2021)
857TiP An open-label, multicenter, phase II study of CLR 131 in patients with relapsed or refractory (R/R) select B-cell malignancies (CLOVER-1) and expansion cohort in patients with waldenstrom macroglobulinemia (CLOVER-WaM)
Authors: S. Ailawadhi, A. Chanan-Khan, J. Peterson, P. Stiff, E. Ibrahim, D. Green, J. Longcor, K. Oliver, M.F. Brown, J. Friend, N. Callander
Journal: Annals of Oncology (2021)
In memoriam Claudio F. Donner
Authors: E. Clini
Journal: Pulmonology (2021)

Claudio F. Donner (1948Donner ( -2021) ) unexpectedly passed away.The news reached most friends and colleagues while still on their annual leave but rapidly spread all around the community astonishing everyone.Too early he left in grief his wife Franca and the daughter Valentina, his family living in Borgomanero a city close to Novara placed in the western-north part of Italy.Claudio Donner was an excellent medical doctor from the moment he graduated from the University of Pavia and subsequently got diplomas in medical specialties.Respiratory medicine was his primary interest in clinical practice and he dedicated himself in particular to the chronic respiratory patients with conditions leading to inability in the daily life.For this reason, he started his career in 1973 at the "Salvatore Maugeri Foundation Research Institute, Center of Veruno" where he served until 2006 as chief of the Division of Pulmo-
1047P Efficacy of checkpoint inhibitors (CPIs) in acral melanoma (AM)
Authors: P. Bhave, T. Ahmed, A.N. Shoushtari, A. Zaremba, J.M. Versluis, J. Mangana, M. Weichenthal, L. Si, T. Lesimple, C. Robert, C. Trojaniello, A. Wicky, R. Heywood, L. Tran, K. Batty, A. Stansfeld, C. Lebbe, J.K. Schwarze, M. Mooradian, M. Carlino
Journal: Annals of Oncology (2021)
134P Enrolment in clinical trials (CT) among patients (pts) with early breast cancer (BC)
Authors: D. Presti, J. Havas, D. Soldato, P. Lapidari, E. Martin, B. Pistilli, A-L. Martin, S. Everhard, C. Jouannaud, C. Levy, O. Rigal, M. Fournier, P. Soulié, M-A. Mouret-Reynier, C. Tarpin, M. Campone, S. Guillermet, F. André, I. Vaz-Luis, A. Di Meglio
Journal: Annals of Oncology (2021)
1741P Malignant effusion-derived non-small cell lung cancer organoid might be a feasible in vitro model for therapeutic screening
Authors: H-M. Wang, C-Y. Zhang, H-J. Chen, Y-F. Li, W-F. Li, K-C. Peng, Q-Y. Gao, S-L. Zhang, J-W. Su, Z-X. Chen, Q. Zhou, C-R. Xu, Z. Wang, J. Su, H-H. Yan, J-J. Yang
Journal: Annals of Oncology (2021)
598P A phase Ib study of enzalutamide (Enza) plus CC-115 in men with metastatic castration-resistant prostate cancer (mCRPC)
Authors: J.L. Zhao, E.S. Antonarakis, H. Cheng, D.J. George, R.R. Aggarwal, W. Abida, B. Decker, T. Smart-Curley, J. Schonhoft, A. Anderson, S. Haywood, E. Riedel, B. Carver, A. Wyatt, F. Feng, K. Knudsen, D.E. Rathkopf
Journal: Annals of Oncology (2021)
Venous Thromboembolism in Patients with Steroid-Refractory Chronic Graft-Versus-Host Disease Receiving Synthetic Retinoid Am80
Authors: Hisakazu Nishimori, Masashi Sawa, Kazuteru Ohashi, Hirohisa Nakamae, Shin-ichiro Fujiwara, Yasuo Mori, Yoshihiro Inamoto, Yoshinobu Maeda
Journal: Blood (2017)
Spotlight influenza: Laboratory-confirmed seasonal influenza in people with acute respiratory illness: a literature review and meta-analysis, WHO European Region, 2004 to 2017
Authors: Sara Belazi, Sonja J Olsen, Caroline Brown, Helen K Green, Piers Mook, Jonathan Nguyen-Van-Tam, Pasi Penttinen, Louise Lansbury
Journal: Eurosurveillance (2021)

Background Across the World Health Organization European Region, there are few estimates of the proportion of people seeking medical care for influenza-like illness or acute respiratory infections and who have laboratory-confirmed seasonal influenza infection. Methods We conducted a meta-analysis of data extracted from studies published between 2004 and 2017 and from sentinel data from the European surveillance system (TESSy) between 2004 and 2018. We pooled within-season estimates by influenza type/subtype, setting (outpatient (OP)/inpatient (IP)) and age group to estimate the proportion of people tested who have laboratory-confirmed and medically-attended seasonal influenza in Europe. Results In the literature review, the pooled proportion for all influenza types was 33% (95% confidence interval (CI): 30–36), higher among OP 36% (95% CI: 33–40) than IP 24% (95% CI: 20–29). Pooled estimates for all influenza types by age group were: 0–17 years, 26% (22–31); 18–64 years, 41% (32–50); ≥ 65 years, 33% (27–40). From TESSy data, 33% (31–34) of OP and 24% (21–27) of IP were positive. The highest proportion of influenza A was in people aged 18–64 years (22%, 16–29). By subtype, A(H1N1)pdm09 was highest in 18–64 year-olds (16%, 11–21%) whereas A(H3N2) was highest in those ≥ 65 years (10%, 2–22). For influenza B, the highest proportion of infections was in those aged 18–64 years (15%, 9–24). Conclusions Laboratory-confirmed influenza accounted for approximately one third of all acute respiratory infections for which medical care was sought during the influenza season.
283P Treatment landscape of HER2-positive metastatic breast cancer (MBC): Results from the Austrian AGMT_MBC-Registry
Authors: S.P. Gampenrieder, G. Rinnerthaler, C. Tinchon, A.L. Petzer, M. Balic, S. Heibl, A. Zabernigg, D. Egle, M. Sandholzer, F. Roitner, J. Andel, P. Pichler, C. Hager, M. Hubalek, M. Knauer, C.F. Singer, R. Greil
Journal: Annals of Oncology (2021)
498P Association between capecitabine efficacy and proton pump inhibitors in patients with stage II-III colorectal cancer: A retrospective multicenter study
Authors: H. Fujii, Y. Kitazume, R. Uozumi, H. Iihara, M. Takahashi, T. Arai, T. Yoshizawa, Y. Murachi, Y. Sato, T. Mikami, K. Hashiguchi, K. Takahashi, Y. Fujita, T. Yamazaki, Y. Hosokawa, I. Morozumi, M. Tsuchiya, A. Yokoyama, H. Hashimoto, M. Yamaguchi
Journal: Annals of Oncology (2021)
1118P Angioside: The role of angiogenesis in lung neuroendocrine tumors according to primary tumor location in left or right parenchyma
Authors: A. La Salvia, R. Carletti, M. Verrico, T. Feola, G. Puliani, F. Sesti, A. Pernazza, R. Mazzilli, E. Giannetta, A. Siciliani, M. Mancini, C. Di Gioia, A. Faggiano
Journal: Annals of Oncology (2021)
560TiP A phase I/IIa study to evaluate the safety and efficacy of CCS1477, a first in clinic inhibitor of p300/CBP, as monotherapy in patients with selected molecular alterations
Authors: S. Crabb, R. Plummer, A. Greystoke, L. Carter, S. Pacey, H. Walter, V.M. Coyle, T. Knurowski, K. Clegg, F. Ashby, N. Pegg, W. West, N. Brooks, A. Hughes, J. de Bono
Journal: Annals of Oncology (2021)
Oral microbiota in the oral-genitourinary axis: identifying periodontitis as a potential risk of genitourinary cancers
Authors: Shuai Yuan, Cheng Fang, Wei-Dong Leng, Lan Wu, Bing-Hui Li, Xing-Huan Wang, Hailiang Hu, Xian-Tao Zeng
Journal: Military Medical Research (2021)

Periodontitis has been proposed as a novel risk factor of genitourinary cancers: although periodontitis and genitourinary cancers are two totally distinct types of disorders, epidemiological and clinical studies, have established associations between them. Dysbiosis of oral microbiota has already been established as a major factor contributing to periodontitis. Recent emerging epidemiological evidence and the detection of oral microbiota in genitourinary organs indicate the presence of an oral-genitourinary axis and oral microbiota may be involved in the pathogenesis of genitourinary cancers. Therefore, oral microbiota provides the bridge between periodontitis and genitourinary cancers. We have carried out this narrative review which summarizes epidemiological studies exploring the association between periodontitis and genitourinary cancers. We have also highlighted the current evidence demonstrating the capacity of oral microbiota to regulate almost all hallmarks of cancer, and proposed the potential mechanisms of oral microbiota in the development of genitourinary cancers.
Cardiac Surgery in Women in the Current Era: What Are the Gaps in Care?
Authors: Leslie Cho, Melina R. Kibbe, Faisal Bakaeen, Niti R. Aggarwal, Melinda B. Davis, Tara Karmalou, Jennifer S. Lawton, Maral Ouzounian, Ourania Preventza, Andrea M. Russo, Annie-Laurie W. Shroyer, Brittany A. Zwischenberger, Kathryn J. Lindley
Journal: Circulation (2021)

Cardiovascular disease remains the leading cause of morbidity and mortality for women in United States and worldwide. One in 3 women dies from cardiovascular disease, and 45% of women &gt;20 years old have some form of CVD. Historically, women have had higher morbidity and mortality after cardiac surgery. Sex influences pathogenesis, pathophysiology, presentation, postoperative complications, surgical outcomes, and survival. This review summarizes current cardiovascular surgery outcomes as they pertain to women. Specifically, this article seeks to address whether sex disparities in research, surgical referral, and outcomes still exist and to provide strategies to close these gaps. In addition, with the growing population of women of reproductive age with cardiovascular disease and cardiovascular risk factors, indications for cardiac surgery arise in pregnant women. The current review will also address the unique issues associated with this special population.
1213P Clinical utility of liquid biopsy for the early diagnosis of EGFR mutant advanced lung cancer in a real-life setting (CLEAR)
Authors: R. Nassabein, X. Weng, R. Alameddine, F. Blanc-Durand, W. Belkaid, M. Tehfe, M. Florescu, B. Routy, N. Blais
Journal: Annals of Oncology (2021)
Decellularized extracellular matrix scaffolds: Recent trends and emerging strategies in tissue engineering
Authors: Xuewei Zhang, Xi Chen, Hua Hong, Rubei Hu, Jiashang Liu, Changsheng Liu
Journal: Bioactive Materials (2021)

The application of scaffolding materials is believed to hold enormous potential for tissue regeneration. Despite the widespread application and rapid advance of several tissue-engineered scaffolds such as natural and synthetic polymer-based scaffolds, they have limited repair capacity due to the difficulties in overcoming the immunogenicity, simulating in-vivo microenvironment, and performing mechanical or biochemical properties similar to native organs/tissues. Fortunately, the emergence of decellularized extracellular matrix (dECM) scaffolds provides an attractive way to overcome these hurdles, which mimic an optimal non-immune environment with native three-dimensional structures and various bioactive components. The consequent cell-seeded construct based on dECM scaffolds, especially stem cell-recellularized construct, is considered an ideal choice for regenerating functional organs/tissues. Herein, we review recent developments in dECM scaffolds and put forward perspectives accordingly, with particular focus on the concept and fabrication of decellularized scaffolds, as well as the application of decellularized scaffolds and their combinations with stem cells (recellularized scaffolds) in tissue engineering, including skin, bone, nerve, heart, along with lung, liver and kidney.
1100MO Molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms
Authors: H. Sorbye, A. Venizelos, H. Elvebakken, A. Perren, I.M.B. Lothe, G.O. Hjortland, A. Sundlov, J. Svensson, H. Garresori, C. Kersten, M. Krogh, S. Detlefsen, S. Knappskog
Journal: Annals of Oncology (2021)
767P Retrospective analysis of the impact of bevacizumab dose-intensity on the survival of platinum-resistant ovarian cancer patients
Authors: J.A. Bahena, L. Cetina-Pérez, D. Gallardo-Rincón, P. Cabrera-Galeana, G.C. Alamilla Garcia, E. Montes-Servín, E. Montes-Servín, E. Varela-Santoyo
Journal: Annals of Oncology (2021)
LBA55 Primary analysis of a phase II single-arm trial of trastuzumab deruxtecan (T-DXd) in western patients (Pts) with HER2-positive (HER2+) unresectable or metastatic gastric or gastroesophageal junction (GEJ) cancer who progressed on or after a trastuzumab-containing regimen
Authors: E. van Cutsem, M. Di Bartolomeo, E. Smyth, I. Chau, H. Park, S. Siena, S. Lonardi, Z.A. Wainberg, J.A. Ajani, J. Chao, J. Seraj, Y. Kawaguchi, A. Qin, J. Singh, G. Meinhardt, G. Ku
Journal: Annals of Oncology (2021)
Child maltreatment and incident mental disorders in middle and older ages: a retrospective UK Biobank cohort study
Authors: John M Macpherson, Stuart R Gray, Patrick Ip, Marianne McCallum, Peter Hanlon, Paul Welsh, Ko Ling Chan, Frances S Mair, Carlos Celis-Morales, Helen Minnis, Jill P Pell, Frederick K Ho
Journal: The Lancet Regional Health - Europe (2021)

Understanding the mental health consequences of child maltreatment at different life stages is important in accurately quantifying the burden of maltreatment. This study investigated the association between child maltreatment and incident mental disorders in middle and older age as well as the potential mediators and moderators.This is a retrospective cohort study of 56,082 participants from UK Biobank. Child maltreatment was recalled using the Childhood Trauma Screener. Incident mental disorders, including depressive, anxiety and affective disorders, behavioural syndromes, post-traumatic stress disorder (PTSD), schizophrenia, substance abuse, and dementia, after baseline assessment were ascertained through linkage to primary care records.There was a dose-response relationship between child maltreatment and mental disorder. Those who experienced three or more maltreatment types had the highest risk of all mental disorders (HR 1.85, 95% CI: 1.67-2.06) followed by those who experienced two (HR 1.48, 95% CI: 1.35-1.63) and then one (HR 1.26, 95% CI: 1.19-2.35). Child maltreatment was most strongly associated with PTSD (HR 1.59, 95% CI: 1.20-2.10 P=0.001). The excess risk was largely unexplained by the included mediators. The association between child maltreatment and all mental disorders were stronger among participants who binge drank (Pinteraction=0.003) or had few social visits (Pinteraction=0.003).The mental health consequence of child maltreatment could last decades, even among those who had no recorded mental disorders in early adulthood. In the absence of strong mediators, prevention of child maltreatment remains the priority.Wellcome Trust Institutional Strategic Support Fund.
1212P Afatinib for the treatment of NSCLC with uncommon EGFR mutations: An updated database of 1023 cases
Authors: J.Y.C-H. Yang, M. Schuler, S. Popat, S. Miura, K. Park, A. Passaro, F. de Marinis, F. Solca, A. Märten, E.S. Kim
Journal: Annals of Oncology (2021)